You are viewing an incomplete version of our website. Please click to reload the website as full version.

C-Type Lectin Domain Family 9, Member A (CLEC9A) ELISA Kits

CLEC9A is a group V C-type lectin-like receptor (CTLR) that functions as an activation receptor and is expressed on myeloid lineage cells (Huysamen et al., 2008 [PubMed 18408006]).[supplied by OMIM, Aug 2008].. Additionally we are shipping CLEC9A Antibodies (116) and CLEC9A Proteins (7) and many more products for this protein.

list all ELISA KIts Gene Name GeneID UniProt
CLEC9A 283420 Q6UXN8
CLEC9A 502901 D4AD02
CLEC9A 232414 Q8BRU4
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Order online
  • orders@antibodies-online.com

Top CLEC9A ELISA Kits at antibodies-online.com

Showing 9 out of 10 products:

Catalog No. Reactivity Sensitivity Range Quantity Supplier Delivery Price Details
Human 0.078 ng/ml 0.312-20 ng/mL 96 Tests Log in to see 11 to 13 Days
$910.56
Details
Monkey
96 Tests Log in to see 16 to 21 Days
$999.43
Details
Dog
96 Tests Log in to see 16 to 21 Days
$999.43
Details
Mouse
96 Tests Log in to see 16 to 21 Days
$999.43
Details
Chicken
96 Tests Log in to see 16 to 21 Days
$999.43
Details
Rabbit
96 Tests Log in to see 16 to 21 Days
$999.43
Details
Rat
96 Tests Log in to see 16 to 21 Days
$999.43
Details
Sheep
96 Tests Log in to see 16 to 21 Days
$999.43
Details
Guinea Pig
96 Tests Log in to see 16 to 21 Days
$999.43
Details

More ELISA Kits for CLEC9A Interaction Partners

Human C-Type Lectin Domain Family 9, Member A (CLEC9A) interaction partners

  1. Data indicate that blood dendritic cell antigen 3 BDCA3 (show THBD ELISA Kits)(+) and C-type lectin (show MBL2 ELISA Kits) domain family 9, member A (show CXCL14 ELISA Kits) CLEC9A(+) dendritic cells (DC) are of major importance in the induction of anti-viral and anti-tumor immunity.

  2. Activated dendritic cell subsets expressing CD141/CLEA9A/CD1c, likely recruited into the tubulointerstitium, are positioned to play a role in the development of fibrosis and, thus, progression to chronic kidney disease.

  3. study showsn that the DNGR-1 ligand is preserved from yeast to man and corresponds to the F-actin component of the cellular cytoskeleton; identification of F-actin as a DNGR-1 ligand suggests that cytoskeletal exposure is a universal sign of cell damage that can be targeted by the innate immune system to initiate immunity

  4. High expression of DNGR-1 specifically and universally identifies a unique dendritic cells subset in mouse and humans.

  5. propose that Clec9A provides targeted recruitment of the adaptive immune system during infection and can also be utilized to enhance immune responses generated by vaccines.

  6. Data show that CLEC9A is only expressed on immature BDCA3 (show THBD ELISA Kits)(+) myeloid dendritic cells (mDCs).

  7. For production of cytotoxic T cells, transge (show LY75 ELISA Kits)nic DEC-205 and Clec9A, but (show CLEC12A ELISA Kits)not Clec12A, are effective targets for antibody-mediated delivery of antigens for vaccination, although only in the presence of adjuvants.

  8. A population of human dendritic cells (DC) that expresses DNGR-1 (CLEC9A) and high levels of BDCA3 (show THBD ELISA Kits) and resembles mouse CD8alpha+ DCs in phenotype and function, is characterized.

  9. The paper cited (J Clin Invest. 2008 Jun;118(6):2098-110) is the first characterization of human and mouse CLEC9A (a.k.a DNGR-1)

  10. CLEC9A functions as an activation receptor

Mouse (Murine) C-Type Lectin Domain Family 9, Member A (CLEC9A) interaction partners

  1. Study found presence of DNGR-1 in the brain, providing a potential marker for the study of a specific denditritic brain cell subset

  2. A dependence on DNGR-1 for RSV-specific CD8 (show CD8A ELISA Kits)(+) T-cell responses was observed.

  3. Genetic tracing of DNGR-1 expression history specifically marks cells traditionally ascribed to the dendritic cells lineage, and this restriction is maintained after inflammation.

  4. Clec9A-positive dendritic cells control susceptibility of mice to experimental cerebral malaria.

  5. High expression of DNGR-1 specifically and universally identifies a unique dendritic cells subset in mouse and humans.

  6. Loss of DNGR-1 impaired the CD8 (show CD8A ELISA Kits) positive lymphocyte cytotoxic response to vaccinia virus, especially against those virus strains that are most dependent on cross-presentation.

  7. DNGR-1 regulated cross-priming in non-infectious settings such as immunization with antigen-bearing dead cells, as well as in highly immunogenic situations such as infection with herpes simplex virus type 1.

  8. propose that Clec9A provides targeted recruitment of the adaptive immune system during infection and can also be utilized to enhance immune responses generated by vaccines.

  9. Data show that targeting of antigen to Clec9A in batf3 (show BATF3 ELISA Kits) null mice produced enhanced antibody responses.

  10. For production of cytotoxic T cells, DEC-205 (show LY75 ELISA Kits) and Clec9A, but not Clec12A (show CLEC12A ELISA Kits), are effective targets for antibody-mediated delivery of antigens for vaccination, although only in the presence of adjuvants.

CLEC9A Antigen Profile

Antigen Summary

CLEC9A is a group V C-type lectin-like receptor (CTLR) that functions as an activation receptor and is expressed on myeloid lineage cells (Huysamen et al., 2008

Gene names and symbols associated with CLEC9A

  • C-type lectin domain family 9, member A (CLEC9A) antibody
  • C-type lectin domain family 9, member A (Clec9a) antibody
  • C-type lectin domain family 9, member a (Clec9a) antibody
  • 9830005G06Rik antibody
  • DNGR-1 antibody
  • DNGR1 antibody
  • RGD1562513 antibody
  • UNQ9341 antibody

Protein level used designations for CLEC9A

C-type lectin domain family 9 member A , HEEE9341 , dendritic cell natural killer lectin group receptor 1

GENE ID SPECIES
283420 Homo sapiens
502901 Rattus norvegicus
232414 Mus musculus
Selected quality suppliers for CLEC9A (CLEC9A) ELISA Kits
Did you look for something else?